Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.100 | None | 0.956 | 68 | 7 | 1999 | 2019 | ||||||||
|
laminin subunit gamma 1 | 0.628 | 0.654 | 1.00 |
|
disease | 0.410 | None | 1.000 | 5 | 7 | 2013 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 0.972 | 106 | 6 | 1992 | 2020 | ||||||||
|
PMS1 homolog 2, mismatch repair system component | 0.484 | 0.808 | 4.5E-27 |
|
disease | 0.500 | strong | 0.967 | 60 | 6 | 1998 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.800 | strong | 0.966 | 59 | 6 | 1993 | 2020 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
disease | 0.400 | None | 0.965 | 57 | 6 | 1998 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 26 | 6 | 2002 | 2019 | ||||||||
|
transforming growth factor beta receptor 1 | 0.451 | 0.885 | 0.85 |
|
disease | 0.400 | None | 0.960 | 25 | 6 | 2003 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 18 | 6 | 2007 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
disease | 0.100 | None | 1.000 | 17 | 6 | 1994 | 2020 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
disease | 0.400 | None | 0.875 | 16 | 6 | 2005 | 2018 | ||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
disease | 0.500 | None | 0.929 | 14 | 6 | 1991 | 2018 | ||||||||
|
cytochrome P450 family 24 subfamily A member 1 | 0.518 | 0.692 | 3.2E-23 |
|
disease | 0.100 | None | 1.000 | 13 | 6 | 2010 | 2018 | ||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
disease | 0.420 | None | 1.000 | 8 | 6 | 2011 | 2019 | ||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
disease | 0.100 | None | 1.000 | 7 | 6 | 2013 | 2019 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.060 | None | 0.833 | 6 | 6 | 2007 | 2018 | ||||||||
|
phospholipase C epsilon 1 | 0.572 | 0.654 | 5.7E-11 |
|
disease | 0.060 | None | 0.833 | 6 | 6 | 2011 | 2016 | ||||||||
|
folate hydrolase 1 | 0.453 | 0.885 | 6.2E-09 |
|
disease | 0.340 | None | 0.750 | 4 | 6 | 2001 | 2015 | ||||||||
|
UDP glucuronosyltransferase family 1 member A10 | 0.588 | 0.615 | 4.6E-19 |
|
disease | 0.040 | None | 1.000 | 4 | 6 | 2011 | 2016 | ||||||||
|
X-ray repair cross complementing 4 | 0.528 | 0.769 | 8.3E-07 |
|
disease | 0.040 | None | 1.000 | 4 | 6 | 2010 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1500 | 0.760 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 6 | 2013 | 2019 | |||||||||
|
UDP glucuronosyltransferase family 1 member A8 | 0.588 | 0.654 | 1.3E-09 |
|
disease | 0.030 | None | 1.000 | 3 | 6 | 2011 | 2016 | ||||||||
|
H19 imprinted maternally expressed transcript | 0.494 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 6 | 2001 | 2001 | |||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.984 | 61 | 5 | 1995 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.826 | 46 | 5 | 2000 | 2017 |